LRRK2 and Parkinson disease: This matches experimental evidence showing that p.R1441C impairs PKA-mediated phosphorylation of S1443, disrupts LRRK2’s interaction with 14-3-3 proteins and modulates its kinase activity37 (Fig. 5c), reinforcing a known pathogenic mechanism in Parkinson’s disease.